CAHtalyst studies

Neurocrine reports positive phase 3 data for hyperplasia drug in children

Neurocrine reports positive phase 3 data for hyperplasia drug in children

Anika Sharma

Just a month after the successful outcome of Neurocrine Biosciences’ phase 3 study for crinecerfont in adults with hyperplasia, the ...